Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H₃ receptor antagonists/inverse agonists containing triazole moiety

References

• Beghi E. Addressing the burden of epilepsy: many unmet needs. Pharmacol Res 2016;107:79–84.
   PubMed Web of Science ®Google Scholar
• Singh SP, Ankaraneni RS, Antony AR. Evidence-based guidelines for the management of epilepsy. Neurol India 2017;65:S6–S11.
   PubMedGoogle Scholar
• Gaitatzis A, Sander JW. The long-term safety of antiepileptic drugs. CNS Drugs 2013;27:435–55.
   PubMed Web of Science ®Google Scholar
• Błaszczyk B, Lasón W, Czuczwar S. Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep 2015;67:426–34.
   PubMed Web of Science ®Google Scholar
• Ferrer P, Ballarín E, Sabaté M, et al. Antiepileptic drugs and suicide: a systematic review of adverse effects. Neuroepidemiology 2014;42:107–20.
   PubMed Web of Science ®Google Scholar
• Kiviranta T, Tuomisto L, Airaksinen EM. Histamine in cerebrospinal fluid of children with febrile convulsions. Epilepsia 1995;36:276–80.
   PubMed Web of Science ®Google Scholar
• Zhang LS, Chen Z, Huang YW, et al. Effects of endogenous histamine on seizure development of pentylenetetrazole-induced kindling in rats. Pharmacology 2003;69:27–32.
   PubMed Web of Science ®Google Scholar
• Kamei C, Ishizawa K, Kakinoki H, Fukunaga M. Histaminergic mechanisms in amygdaloid-kindled seizures in rats. Epilepsy Res 1998;30:187–94.
   PubMed Web of Science ®Google Scholar
• Yokoyama H. The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain. Brain Dev 2001;23:542–7.
   PubMed Web of Science ®Google Scholar
• Chen Z, Li WD, Zhu LJ, et al. Effects of histidine, a precursor of histamine, on pentylenetetrazole-induced seizures in rats. Acta Pharmacol Sin 2002;23:361–6.
   PubMed Web of Science ®Google Scholar
• Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983;302:832–7.
   PubMed Web of Science ®Google Scholar
• Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001;63:637–72.
   PubMed Web of Science ®Google Scholar
• Lu CW, Lin TY, Chang CY, et al. Ciproxifan, a histamine H3 receptor antagonist and inverse agonist, presynaptically inhibits glutamate release in rat hippocampus. Toxicol Appl Pharmacol 2017;319:12–21.
   PubMed Web of Science ®Google Scholar
• Bhowmik M, Khanam R, Vohora D. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br J Pharmacol 2012;167:1398–414.
   PubMed Web of Science ®Google Scholar
• Kakinoki H, Ishizawa K, Fukunaga M, et al. The effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in rats. Brain Res Bull 1998;46:461–5.
   PubMed Web of Science ®Google Scholar
• Vohora D, Pal SN, Pillai KK. Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice. Life Sci 2000;66:PL297–301.
   PubMed Web of Science ®Google Scholar
• Ishizawa K, Chen Z, Okuma C, et al. Participation of GABAergic and histaminergic systems in inhibiting amygdaloid kindled seizures. Jpn J Pharmacol 2000;82:48–53.
   PubMedGoogle Scholar
• Vohora D, Pal SN, Pillai KK. Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacol Biochem Behav 2001;68:735–41.
   PubMed Web of Science ®Google Scholar
• Zhang LS, Chen Z, Ren K, et al. Effects of clobenpropit on pentylenetetrazole-kindled seizures in rats. Eur J Pharmacol 2003;482:169–75.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Onodera K, Maeyama K, et al. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur J Pharmacol 1994;260:23–8.
   PubMed Web of Science ®Google Scholar
• Hirai T, Okuma C, Harada C, et al. Development of amygdaloid kindling in histidine decarboxylase-deficient and histamine H1 receptor-deficient mice. Epilepsia 2004;45:309–13.
   PubMed Web of Science ®Google Scholar
• Uma Devi P, Manocha A, Khanam R, Vohora D. Beneficial interaction between clobenpropit and pyridoxine in prevention of electroshock-induced seizures in mice: lack of histaminergic mechanisms. Hum Exp Toxicol 2011;30:84–8.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Onodera K, Iinuma K, Watanabe T. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice. Eur J Pharmacol 1993;234:129–33.
   PubMed Web of Science ®Google Scholar
• Sadek B, Saad A, Subramanian D, et al. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats. Neuropharmacology 2016;106:46–55.
   PubMed Web of Science ®Google Scholar
• Kuder KJ, Łażewska D, Kaleta M, et al. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands. Bioorg Med Chem 2017;25:2701–12.
   PubMed Web of Science ®Google Scholar
• Alachkar A, Łażewska D, Latacz G, et al. Studies on anticonvulsant effects of novel histamine H3R antagonists in electrically and chemically induced seizures in rats. Int J Mol Sci 2018;19:3386.
   Web of Science ®Google Scholar
• Szczepańska K, Karcz T, Mogilski S, et al. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands. Eur J Med Chem 2018;152:223–34.
   PubMed Web of Science ®Google Scholar
• Łażewska D, Kaleta M, Hagenow S, et al. Novel naphthyloxy derivatives – potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation. Bioorg Med Chem 2018;26:2573–85.
   PubMed Web of Science ®Google Scholar
• Sadek B, Schwed JS, Subramanian D, et al. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties. Eur J Med Chem 2014;77:269–79.
   PubMed Web of Science ®Google Scholar
• Sadek B, Saad A, Schwed JS, et al. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists. Drug Des Devel Ther 2016;10:3633–51.
   PubMed Web of Science ®Google Scholar
• Schwartz J-C.The histamine H3 receptor: from discovery to clinical trials with pitolisant. British Journal of PharmacologyBr J Pharmacol 2011;163:713–21.
   PubMed Web of Science ®Google Scholar
• Kasteleijn-Nolst Trenité D, Parain D, Genton P, et al. Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity model. Epilepsy Behav 2013;28:66–70.
   PubMed Web of Science ®Google Scholar
• Deng XQ, Wei CX, Li FN, et al. Design and synthesis of 10-alkoxy-5, 6-dihydro-triazolo[4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity. Eur J Med Chem 2010;45:3080–6.
   PubMed Web of Science ®Google Scholar
• Cui XS, Chen J, Chai KY, Lee JS, et al. Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1,2,4-triazoles. Med Chem Res 2009;18:49–58.
   Web of Science ®Google Scholar
• Ayati A, Emami S, Foroumadi A. The importance of triazole scaffold in the development of anticonvulsant agents. Eur J Med Chem 2016;109:380–92.
   PubMed Web of Science ®Google Scholar
• Guan LP, Quan ZS. 3,4-DHQLO and triazole and its related analogues with anticonvulsant effects. Mini Rev Med Chem 2016;16:323–42.
   PubMed Web of Science ®Google Scholar
• Song MX, Deng XQ. Recent developments on triazole nucleus in anticonvulsant compounds: a review. J Enzyme Inhib Med Chem 2018;33:453–78.
   PubMed Web of Science ®Google Scholar
• Guan LP, Zhao DH, Jiang Z, et al. Evaluation of anticonvulsant activity of QUAN-0806 in various murine experimental seizure models. Pharmazie 2009;64:248–51.
   PubMed Web of Science ®Google Scholar
• Deng XQ, Quan LN, Song MX, et al. Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones and their derivatives. Eur J Med Chem 2011;46:2955–63.
   PubMed Web of Science ®Google Scholar
• Deng XD, Song MX, Wang SB, Quan ZS. Synthesis and evaluation of the anticonvulsant activity of 8-alkoxy-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine derivatives. J Enzyme Inhib Med Chem 2014;29:272–80.
   PubMed Web of Science ®Google Scholar
• Kaproń B, Łuszczki J, Paneth A, et al. Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione – a novel anticonvulsant drug candidate. Int J Med Sci 2017;14:741–9.
   PubMed Web of Science ®Google Scholar
• Kaproń B, Łuszczki JJ, Płazińska A, et al. Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies. Eur J Pharm Sci 2019;129:42–57.
   PubMed Web of Science ®Google Scholar
• Huang W, Tang T, Shi Y, et al. Searching for the multi-target-directed ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities. Bioorg Med Chem 2011;19:7158–67.
   PubMed Web of Science ®Google Scholar
• Shi Y, Sheng R, Zhong T, et al. Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor. PLoS One 2012;7:e42185.
   PubMed Web of Science ®Google Scholar
• Shimamura T, Shiroishi M, Weyand S, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011;475:65–70.
   PubMed Web of Science ®Google Scholar
• Kim S-K, Fristrup P, Abrol R, Goddard WA. Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trials. J Chem Inf Model 2011;51:3262–74.
   PubMed Web of Science ®Google Scholar
• Ghamari N, Zarei O, Reiner D, et al. Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects. Chem Biol Drug Des 2019;93:832–43.
   PubMed Web of Science ®Google Scholar
• Song MX, Wang ZY, He SH, et al. Synthesis and evaluation of the anticonvulsant activities of 4-(2-(alkylthio)benzo[d]oxazol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-ones. Molecules 2018;23:756.
   Web of Science ®Google Scholar